![Ariella Kelman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/09/2026
Dr. Ariella Kelman, MD, is a Chief Medical Officer at TRex Bio, Inc. and a Chief Medical Officer at BT Bidco, Inc. She received her undergraduate degree from the University of California, Los Angeles and a doctorate degree from Tel-Aviv University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TREX BIO, INC. -.--% | 08/10/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2023 |
| TREX BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Trex Bio, Inc.
 Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that engages in autoimmune and inflammatory disease discovery activities | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
